Query | 95 results

Show me

Companies

Cryptocurrencies

People

Venture Capital Firms

Show All (18)

Select...

where

Sarepta Therapeutics

Name	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Patent Inventor Names	Date of Patent

‌ US Patent 11555189 Antisense oligomer compounds	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11555189		January 17, 2023
‌ US Patent 9416361 Splice-region antisense composition and method	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9416361		August 16, 2016
‌ US Patent 10337003 Compositions for treating muscular dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10337003	Edward M. Kaye	July 2, 2019
‌ US Patent 10066228 Oligonucleotides for treating expanded repeat diseases		Sarepta Therapeutics	United States Patent and Trademark Office	10066228		September 4, 2018
‌ US Patent 11472824 Processes for preparing phosphorodiamidate morpholino oligomers	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11472824		October 18, 2022
‌ US Patent 11384105 Processes for preparing oligomers	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11384105	Baozhong CaiDiane Elizabeth FrankKatie ThomasMitchell Martini	July 12, 2022
‌ US Patent 9506058 Compositions for treating muscular dystrophy		Sarepta Therapeutics	United States Patent and Trademark Office	9506058	Edward M. Kaye	November 29, 2016
‌ US Patent 10364431 Compositions for treating muscular dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10364431		July 30, 2019
‌ US Patent 11472866 Adeno-associated virus antibodies, fragments thereof and encoding polynucleotides	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11472866	Danielle GriffinLouise Rodino-KlapacSohrab Khan	October 18, 2022
‌ US Patent 11395855 Exon skipping oligomer conjugates for muscular dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11395855		July 26, 2022
‌ US Patent 11642364 Exon skipping oligomer conjugates for muscular dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11642364	Gunnar J. HansonMarco A. Passini	May 9, 2023
‌ US Patent 11491238 Exon skipping oligomer conjugates for muscular dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11491238	Frederick Joseph SchnellRichard K. Bestwick	November 8, 2022
‌ US Patent 10533174 Splice-region antisense composition and method	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10533174	Patrick L. IversenRobert Hudziak	January 14, 2020
‌ US Patent 10006031 Antisense composition and method for treating muscle atrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10006031	Alan P. TimminsDwight D. WellerPatrick L. Iversen	June 26, 2018
‌ US Patent 11382981 Exon skipping oligomer conjugates for muscular dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11382981	Gunnar J. HansonMarco A. Passini	July 12, 2022
‌ US Patent 11338041 Exon skipping oligomer conjugates for muscular dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	11338041	Frederick Joseph SchnellGunnar J. HansonMarco A. Passini	May 24, 2022
‌ US Patent 10875880 Processes for preparing oligomers	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10875880		December 29, 2020
‌ US Patent 9499583 Antibacterial antisense oligonucleotide and method	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9499583	Bruce L. GellerDwight D. WellerJed N. HassingerLucas D. Tilley	November 22, 2016
‌ US Patent 10961262 Processes for preparing phosphorodiamidate morpholino oligomers	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10961262	Baozhong CaiKatie ThomasMitchell MartiniRoss Shimabuku	March 30, 2021
‌ US Patent 9249243 Antibacterial antisense oligonucleotide and method	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9249243	Bruce L. GellerDwight D. WellerJed N. HassingerLucas D. Tilley	February 2, 2016
‌ US Patent 10947533 Processes for preparing phosphorodiamidate morpholino oligomers	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10947533		March 16, 2021
‌ US Patent 10144762 Antibacterial antisense oligonucleotide and method	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	10144762	Bruce L. GellerDwight D. WellerJed N. HassingerLucas D. Tilley	December 4, 2018
‌ US Patent 9278987 Functionally-modified oligonucleotides and subunits thereof	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	9278987	Bao Zhong CaiDwight D. WellerGunnar J. HansonMing Zhou	March 8, 2016
‌ US Patent 8835402 Compound and method for treating myotonic dystrophy	Sarepta Therapeutics	Sarepta Therapeutics	United States Patent and Trademark Office	8835402	Gunnar J. HansonRyszard Kole	September 16, 2014
‌ US Patent 9238042 Antisense modulation of interleukins 17 and 23 signaling		Sarepta Therapeutics	United States Patent and Trademark Office	9238042	Dan V. MourichFrederick J. SchnellGunnar J. HansonPatrick L. Iversen	January 19, 2016

Unlock 85 more patents

Upgrade your workspace for full access to millions of entities in the Golden Knowledge Graph.

Results per page:

95 results

0 selected

95 results

0 selected